Safety, immunogenicity, and clinical efficacy of durvalumab in combination with folate receptor alpha vaccine TPIV200 in patients with advanced ovarian cancer: a phase II trial
================================================================================================================================================================================

* Dmitriy Zamarin
* Sven Walderich
* Aliya Holland
* Qin Zhou
* Alexia E Iasonos
* Jean M Torrisi
* Taha Merghoub
* Lewis F Chesebrough
* Autumn S Mcdonnell
* Jacqueline M Gallagher
* Yanyun Li
* Travis J Hollmann
* Rachel N Grisham
* Courtney L Erskine
* Mathew S Block
* Keith L Knutson
* Roisin E O’Cearbhaill
* Carol Aghajanian
* Jason A Konner